A transcriptome profile in hepatocellular carcinomas based on integrated analysis of microarray studies

BACKGROUND: Despite new treatment options for hepatocellular carcinomas (HCC) recently, 5-year survival remains poor, ranging from 50 to 70%, which may attribute to the lack of early diagnostic biomarkers. Thus, developing new biomarkers for early diagnosis of HCC, is extremely urgent, aiming to dec...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diagn Pathol
Hlavní autoři: Wang, Feifei, Wang, Ruliang, Li, Qiuwen, Qu, Xueling, Hao, Yixin, Yang, Jingwen, Zhao, Huixia, Wang, Qian, Li, Guanghui, Zhang, Fengyun, Zhang, He, Zhou, Xuan, Peng, Xioumei, Bian, Yang, Xiao, Wenhua
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5237304/
https://ncbi.nlm.nih.gov/pubmed/28086821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-016-0596-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky